THE STORY OF SALMOSS BIOTECH
SALMOSS BIOTECH was born as a result of the invention of a new osteoconductive biomaterial in the context of Dr. Muñoz’s PhD program. This innovation opened the opportunity for productive and commercial development.
With this inspiration, Dr. Muñoz invited Gastón Dupre to be part of this project by founding SALMOSS BIOTECH in July 2023. Shortly after, an important agreement was signed with the Pontifical Catholic University of Chile to scientifically validate the modifications to the original product that give Salmoss its unique properties.
In November, SALMOSS BIOTECH was selected by MIT for the exclusive and demanding IDEA 2 program
